Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Raw Materials: 2021-2024

Historic Raw Materials for Mirum Pharmaceuticals (MIRM) over the last 3 years, with Dec 2024 value amounting to $3.0 million.

  • Mirum Pharmaceuticals' Raw Materials rose 2.83% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year increase of 2.83%. This contributed to the annual value of $3.0 million for FY2024, which is 1.07% up from last year.
  • According to the latest figures from FY2024, Mirum Pharmaceuticals' Raw Materials is $3.0 million, which was up 1.07% from $3.0 million recorded in FY2023.
  • In the past 5 years, Mirum Pharmaceuticals' Raw Materials registered a high of $3.0 million during FY2024, and its lowest value of $856,000 during FY2021.
  • Its 2-year average for Raw Materials is $3.0 million, with a median of $3.0 million in 2023.
  • Data for Mirum Pharmaceuticals' Raw Materials shows a peak YoY climbed of 1.07% (in 2024) over the last 5 years.
  • Mirum Pharmaceuticals' Raw Materials (Yearly) stood at $856,000 in 2021, then reached $3.0 million in 2023, then grew by 1.07% to $3.0 million in 2024.